Academic Credentials
  • Ph.D., Medicine, University of Aberdeen, 2002
  • M.S., Biopharmacy, King’s College, University of London, UK, 1991
  • B.Sc., Pharmacology, North East Surrey College of Technology, 1989
  • B.Sc., Applied Biochemistry, Liverpool John Moores University, 1984
Additional Education & Training
  • DipRCPath - Biochemical Toxicology
  • FRCPath - Toxicology
Academic Appointments
  • Industrial Academic Liaison Advisory Board, Aberdeen University, 2010
  • Invited Lecturer, Research & Innovation – Institute of Medical Sciences, Aberdeen University, 2010
  • Invited Lecturer, MSc in Drug Discovery and Translational Biology, University of Edinburgh, 2011
Professional Affiliations
  • Member of Chemical & Biological Metrology Programme Expert Group
  • Fellow of the Royal College of Pathologists

Dr. Morley is an Executive Research and Development Director with over 25 years experience in the Pharmaceutical Industry with small molecules, peptides, antibodies and natural products, directing discovery, safety evaluation and regulatory development from Chemical hit to IND. He also has expertise in Medical Device Safety & Biocompatibility and was the Site Director of Global Medtech Research Centre, establishing Centre of excellence for Biocompatibility, Safety & Efficacy. 

Dr. Morley is a Board-certified Toxicologist with additional expertise in DMPK, Clinical Chemistry, Pharmacology, Bioanalysis, CMC, Medical Affairs and Pharmacovigilance.

Previously Dr. Morley was an Independent Industrial Advisor to Wellcome Trust directing the development of a Multiple Sclerosis Programme, a Member of EPSRC Centre for Innovative Manufacturing in Medical Devices External Advisory Board and and a member of the CH/194 Biological evaluation of Medical Devices BSI eCommittee.

He has a track record of team building, budget management, managing organisational change and directing therapeutic projects from Chemical Hit to IND managing US and EU Regulatory process. He also has experience in supporting Orthopaedic, Sports Medicine & wound healing devices to successful 510K approval.

Dr. Morley has experience of negotiating R&D collaboration contracts, managing industry/academic & biotech/Pharma collaborations, due diligence for in-licence agreements and corporate acquisition. He was a Senior management team member responsible for successful IPO of a UK start-up company.